Real‐World Use of Polynucleotide Injections in Scar Prevention and Management: A Nationwide Survey of Korean Society for Anti‐Aging Dermatology ( <scp>KAAD</scp> ) Dermatologists

BACKGROUND: Scarring is a common dermatologic concern with both aesthetic and functional implications. Polynucleotide (PN)-based injectables have emerged as medical devices in dermatologic practice; however, real-world evidence on their use in scar management remains limited. OBJECTIVE: To describe current clinical practices, application patterns, and perceived roles of PN injections in scar prevention and management among dermatologists belonging to the Korean Society for Anti-Aging Dermatology (KAAD). METHODS: A nationwide, cross-sectional, web-based survey was conducted among KAAD dermatologists. The questionnaire assessed PN use by scar type and etiology, injection techniques, combination strategies, and barriers to adoption. Data were analyzed descriptively. RESULTS: Among 501 respondents, 73.0% reported using PN for scar management. PN was most commonly used for scar prevention (81.4%) and atrophic scars (74.9%), with limited use in hypertrophic scars (10.1%). Intradermal injection over three sessions was the most common approach. PN was frequently incorporated into multimodal protocols, including botulinum toxin, fillers, corticosteroids, bleomycin, and energy-based devices. Reported benefits included improved tissue response, enhanced skin texture, and accelerated wound recovery. Key barriers to PN adoption were product cost (66.7%), limited awareness of its role in scar management (52.6%), and injection discomfort (25.2%). CONCLUSION: PN injections are commonly incorporated into scar prevention and management among KAAD dermatologists participating in this survey, particularly for acne-related, surgical, and traumatic scars. These findings provide real-world insight into current practice patterns and are hypothesis-generating. Prospective studies are needed to define optimal treatment protocols, including dosing, treatment intervals, and combination strategies.

Authors

Institutions

Publication Details

Journal
Journal of Cosmetic Dermatology
Published
2026-05-01
DOI
https://doi.org/10.1111/jocd.70887
Primary Topic
Dermatologic Treatments and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real‐World Use of Polynucleotide Injections in Scar Prevention and Management: A Nationwide Survey of Korean Society for Anti‐Aging Dermatology ( KAAD ) Dermatologists

Boncheol Goo, Kwang Ho Han, Hei Sung Kim, Nark Kyoung Rho
Journal of Cosmetic Dermatology
Dermatologic Treatments and Research
article

Real‐World Use of Polynucleotide Injections in Scar Prevention and Management: A Nationwide Survey of Korean Society for Anti‐Aging Dermatology ( KAAD ) Dermatologists

Boncheol Goo, Kwang Ho Han, Hei Sung Kim, Nark Kyoung Rho
article en

Abstract

BACKGROUND: Scarring is a common dermatologic concern with both aesthetic and functional implications. Polynucleotide (PN)-based injectables have emerged as medical devices in dermatologic practice; however, real-world evidence on their use in scar management remains limited. OBJECTIVE: To describe current clinical practices, application patterns, and perceived roles of PN injections in scar prevention and management among dermatologists belonging to the Korean Society for Anti-Aging Dermatology (KAAD). METHODS: A nationwide, cross-sectional, web-based survey was conducted among KAAD dermatologists. The questionnaire assessed PN use by scar type and etiology, injection techniques, combination strategies, and barriers to adoption. Data were analyzed descriptively. RESULTS: Among 501 respondents, 73.0% reported using PN for scar management. PN was most commonly used for scar prevention (81.4%) and atrophic scars (74.9%), with limited use in hypertrophic scars (10.1%). Intradermal injection over three sessions was the most common approach. PN was frequently incorporated into multimodal protocols, including botulinum toxin, fillers, corticosteroids, bleomycin, and energy-based devices. Reported benefits included improved tissue response, enhanced skin texture, and accelerated wound recovery. Key barriers to PN adoption were product cost (66.7%), limited awareness of its role in scar management (52.6%), and injection discomfort (25.2%). CONCLUSION: PN injections are commonly incorporated into scar prevention and management among KAAD dermatologists participating in this survey, particularly for acne-related, surgical, and traumatic scars. These findings provide real-world insight into current practice patterns and are hypothesis-generating. Prospective studies are needed to define optimal treatment protocols, including dosing, treatment intervals, and combination strategies.

Journal of Cosmetic DermatologyVol. 25(5)
Korea Petroleum Group (South Korea) (KR), The Catholic University of Korea Incheon St. Mary's Hospital (KR), Onnuri Smile Eye Clinic (KR)
Good health and well-being
Openalex Percentile: Top 8%
Dermatologic Treatments and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.